Significance of Fluorescence Colposcopy With Autofluorescence Imaging for Cervical Cancer
NCT01854983 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80
Last updated 2017-05-31
Summary
Clinical Trial to access Significance of fluorescence colposcopy with autofluorescence imaging for the screening of cervical cancer
Conditions
Sponsors & Collaborators
-
Asan Medical Center
lead OTHER
Principal Investigators
-
Jeong-Yeol Park, M.D., Ph.D. · Asan Medical Center
Eligibility
- Min Age
- 20 Years
- Max Age
- 65 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-05-31
- Primary Completion
- 2014-04-30
- Completion
- 2014-04-30
Countries
- South Korea
Study Locations
More Related Trials
-
Cervical Cancer Screening of Postmenopausal Women in Low- and Middle-income Countries Using HPV Self-sampling and Triage by Genotyping and Cytology
NCT07244315 ·Status: COMPLETED
-
Self-sampling and Human Papillomavirus (HPV)-Testing for Unscreened Women in Cervical Cancer Prevention
NCT01588301 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Automated Cervical Cancer Screening Using a Smartphone-based Artificial Intelligence Classifier
NCT04859530 ·Status: RECRUITING ·Phase: NA
-
Cervical Cancer Prevention: From DNA to mRNA? - New Technologies for Cervical Cancer Screening 2
NCT01837693 ·Status: COMPLETED ·Phase: NA
-
A Multicenter Randomized Controlled Study of Photoelectric Detection in Cervical Cancer Screening
NCT06491888 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Accurate Screening and Prevention of Cervical Lesions-- Development of Accurate Screening Methods for Cervical Lesions
NCT05851079 ·Status: UNKNOWN
-
Biomarkerscreening in Cervical Cancer and Its Preinvasive Lesions
NCT02238990 ·Status: ACTIVE_NOT_RECRUITING
-
Human Papillomavirus in Menstrual Blood
NCT01506128 ·Status: COMPLETED
-
Optimizing Cervical Cancer Screening Modalities
NCT03281135 ·Status: UNKNOWN ·Phase: NA
-
Comparison of the Human Papillomavirus (HPV) Type 16 E7-Specific Immune Response Between a Normal Population and Patients With Cervical Lesions
NCT00154583 ·Status: UNKNOWN
-
FDG-PET and Circulating HPV in Patients With Cervical Cancer Treated With Definitive Chemoradiation (II)
NCT03853915 ·Status: RECRUITING ·Phase: NA
-
Colposcopy Versus HPV Testing to Identify Persistent Cervical Precancers
NCT01051895 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Spectroscopy in Diagnosing Dysplasia and Neoplasia in the Cervix in Women Undergoing Colposcopy
NCT00632190 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of a Cervical Cancer Stigma Reduction Intervention Program on Cancer Stigma Score and Cervical Cancer Screening Uptake in Nepal
NCT05489978 ·Status: COMPLETED ·Phase: NA
-
Use of Human Papillomavirus Persistence for Determination of Treatment Efficacy Among Women With Cervical Dysplasia
NCT00931190 ·Status: COMPLETED
-
Cervical Cancer Screening Intervention Among Korean American Women
NCT02594826 ·Status: COMPLETED ·Phase: NA
-
Multilevel HPV Self-Testing Intervention for the Increase of Cervical Cancer Screening Among Women in Appalachia
NCT04411849 ·Status: COMPLETED ·Phase: NA
-
Digital Colposcopy in Finding Cervical Intraepithelial Neoplasia in Patients With An Abnormal Pap Smear
NCT00610662 ·Status: WITHDRAWN
-
Observational Study of Viral BIOmarkers and microRNAs in Tumors Orofarynx and Occult Tumors Positive for Papilloma Virus
NCT05918510 ·Status: RECRUITING
-
A Multicenter Real-world Study of Screening of Cervical Cancer Based on Photoelectric Detection
NCT06481930 ·Status: NOT_YET_RECRUITING
-
Cervical Cancer Screening With Human Papillomavirus Testing
NCT01881659 ·Status: UNKNOWN
-
New Indications for Ultrasound in the Staging of Cervical Cancer
NCT00451945 ·Status: WITHDRAWN ·Phase: NA
-
Detection of Biomarkers in Abnormal Cervical Cells in Women With Abnormal Pap Test Results
NCT00004091 ·Status: COMPLETED
-
Cervical Cancer Screening Study in Brazil
NCT02335372 ·Status: COMPLETED ·Phase: NA
-
Self-sampling and Human Papillomavirus (HPV)-Testing for Unscreened Women in Cervical Cancer Prevention
NCT01014026 ·Status: COMPLETED ·Phase: PHASE3